Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment

Stephanie V. Blank, Paul Christos, John P. Curtin, Noah Goldman, Carolyn D. Runowicz, Joseph A. Sparano, Leonard Liebes, Helen X. Chen, Franco M. Muggia

Research output: Contribution to journal › Article › peer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment'. Together they form a unique fingerprint.

Medicine & Life Sciences